BioCentury | Jun 25, 2009
Strategy

Science for export

...Protein array and antibody analysis systems 2002 Atlanta, Ga. Not available Revitus Inc. (merged with BioVascular Inc....
BioCentury | Oct 15, 2007
Emerging Company Profile

Corporate Profile

BioVascular Inc. San Diego, Calif. Technology: Therapeutics for platelet-mediated disorders Disease focus: Cardiovascular Clinical status: Phase I/II Founded: 2005 by John Parrish and Paul Glidden University collaborators: None Corporate partners: None Number of employees: 8...
BioCentury | Oct 15, 2007
Emerging Company Profile

BioVascular: Platelet mediation

...graft failure by pharmaceutical means is not an area that has seen much success, but BioVascular Inc....
...focus. MRK got together with Domain Associates in 2005 to spin the program out into BioVascular...
...graft indication because none of those products were targeting platelet-mediated initiation of intimal hyperplasia, which BioVascular...
BioCentury | Sep 17, 2007
Company News

BioVascular, Revitus Inc. deal

...terms. The merged company will be called BioVascular and will be headquartered in San Diego. BioVascular's...
...infarction (MI), thrombotic stroke and death in patients who have had a previous cardiovascular event. BioVascular Inc....
BioCentury | Sep 17, 2007
Company News

BioVascular board of directors update

...Diego, Calif. Business: Cardiovascular Appointed: Stephen Hanson, former CEO of Revitus Inc. (now part of BioVascular) WIR...
BioCentury | Sep 17, 2007
Clinical News

BVI-007: Phase Ia started

...Ia trial in healthy volunteers. BioVascular acquired BVI-007 through last week's merger with Revitus Inc. BioVascular Inc....
Items per page:
1 - 6 of 6
BioCentury | Jun 25, 2009
Strategy

Science for export

...Protein array and antibody analysis systems 2002 Atlanta, Ga. Not available Revitus Inc. (merged with BioVascular Inc....
BioCentury | Oct 15, 2007
Emerging Company Profile

Corporate Profile

BioVascular Inc. San Diego, Calif. Technology: Therapeutics for platelet-mediated disorders Disease focus: Cardiovascular Clinical status: Phase I/II Founded: 2005 by John Parrish and Paul Glidden University collaborators: None Corporate partners: None Number of employees: 8...
BioCentury | Oct 15, 2007
Emerging Company Profile

BioVascular: Platelet mediation

...graft failure by pharmaceutical means is not an area that has seen much success, but BioVascular Inc....
...focus. MRK got together with Domain Associates in 2005 to spin the program out into BioVascular...
...graft indication because none of those products were targeting platelet-mediated initiation of intimal hyperplasia, which BioVascular...
BioCentury | Sep 17, 2007
Company News

BioVascular, Revitus Inc. deal

...terms. The merged company will be called BioVascular and will be headquartered in San Diego. BioVascular's...
...infarction (MI), thrombotic stroke and death in patients who have had a previous cardiovascular event. BioVascular Inc....
BioCentury | Sep 17, 2007
Company News

BioVascular board of directors update

...Diego, Calif. Business: Cardiovascular Appointed: Stephen Hanson, former CEO of Revitus Inc. (now part of BioVascular) WIR...
BioCentury | Sep 17, 2007
Clinical News

BVI-007: Phase Ia started

...Ia trial in healthy volunteers. BioVascular acquired BVI-007 through last week's merger with Revitus Inc. BioVascular Inc....
Items per page:
1 - 6 of 6